Pages that link to "Q42934618"
Jump to navigation
Jump to search
The following pages link to Valproate induces DNA demethylation in nuclear extracts from adult mouse brain (Q42934618):
Displaying 50 items.
- Significant Effect of Valproate Augmentation Therapy in Patients With Schizophrenia: A Meta-analysis Study (Q26772965) (← links)
- Advancements in the Underlying Pathogenesis of Schizophrenia: Implications of DNA Methylation in Glial Cells (Q26773159) (← links)
- Active DNA demethylation in post-mitotic neurons: a reason for optimism (Q26829515) (← links)
- Developing epigenetic diagnostics and therapeutics for brain disorders (Q27022987) (← links)
- Schizophrenia: One Coat of Many Colors (Q27500448) (← links)
- An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes (Q28081205) (← links)
- Effects of negative stressors on DNA methylation in the brain: implications for mood and anxiety disorders (Q28822036) (← links)
- Selective α4β2 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neurons (Q30467200) (← links)
- PI3K/AKT/mTOR Signaling Mediates Valproic Acid-Induced Neuronal Differentiation of Neural Stem Cells through Epigenetic Modifications (Q33659344) (← links)
- Epigenetic GABAergic targets in schizophrenia and bipolar disorder (Q34087810) (← links)
- Upregulation of TET1 and downregulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients (Q34297541) (← links)
- PET imaging demonstrates histone deacetylase target engagement and clarifies brain penetrance of known and novel small molecule inhibitors in rat. (Q34343350) (← links)
- Prenatal maternal immune activation causes epigenetic differences in adolescent mouse brain. (Q34370478) (← links)
- Modeling the molecular epigenetic profile of psychosis in prenatally stressed mice (Q34815864) (← links)
- Valproic acid suppresses Nrf2/Keap1 dependent antioxidant protection through induction of endoplasmic reticulum stress and Keap1 promoter DNA demethylation in human lens epithelial cells (Q34940575) (← links)
- The epigenetic landscape of alcoholism (Q35111862) (← links)
- Epigenetic mechanisms may underlie the aetiology of sex differences in mental health risk and resilience. (Q35597036) (← links)
- Whole genome methylation analyses of schizophrenia patients before and after treatment (Q35614046) (← links)
- Epigenetic understanding of gene-environment interactions in psychiatric disorders: a new concept of clinical genetics (Q35833875) (← links)
- DNA methylation and cognitive aging (Q35987240) (← links)
- Epigenetic management of major psychosis (Q36001875) (← links)
- Prenatal antiepileptic exposure associates with neonatal DNA methylation differences (Q36012665) (← links)
- Effect of valproic acid on mitochondrial epigenetics (Q36165223) (← links)
- Classification and adaptive behavior prediction of children with autism spectrum disorder based upon multivariate data analysis of markers of oxidative stress and DNA methylation. (Q36310402) (← links)
- The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. (Q36465820) (← links)
- Epigenetic mechanisms in stroke and epilepsy (Q36465823) (← links)
- Comparative DNA methylation among females with neurodevelopmental disorders and seizures identifies TAC1 as a MeCP2 target gene (Q36980707) (← links)
- DNA demethylating agents synergize with oncolytic HSV1 against malignant gliomas (Q37386851) (← links)
- Differential promoter methylation and histone modification contribute to the brain specific expression of the mouse Mbu-1 gene (Q37461857) (← links)
- Epigenetic treatments for cognitive impairments (Q37877119) (← links)
- A neurochemical basis for an epigenetic vision of psychiatric disorders (1994-2009). (Q37893757) (← links)
- Epigenetic programming of the HPA axis: early life decides (Q37919877) (← links)
- The multidimensional nature of metabolic syndrome in schizophrenia: lessons from studies of one-carbon metabolism and DNA methylation (Q38113237) (← links)
- Epigenetics as a basis for diagnosis of neurodevelopmental disorders: challenges and opportunities (Q38217964) (← links)
- Role of DNA methylation and the DNA methyltransferases in learning and memory (Q38264414) (← links)
- DNA methylation and demethylation as targets for antipsychotic therapy. (Q38264416) (← links)
- Understanding the epigenetics of neurodevelopmental disorders and DOHaD. (Q38364544) (← links)
- Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies (Q38425127) (← links)
- DNA methylation: dynamic and stable regulation of memory (Q38472630) (← links)
- Prospects for the development of epigenetic drugs for CNS conditions (Q38497844) (← links)
- Epigenetics and ADHD: Toward an Integrative Approach of the Disorder Pathogenesis (Q38700467) (← links)
- Epigenetic Downregulation of Scn3a Expression by Valproate: a Possible Role in Its Anticonvulsant Activity. (Q38783217) (← links)
- Childhood adversity and epigenetic regulation of glucocorticoid signaling genes: Associations in children and adults (Q38806319) (← links)
- Epigenetic Mechanisms in Psychiatric Diseases and Epigenetic Therapy (Q38946328) (← links)
- Epigenetics, nutrition and mental health. Is there a relationship? (Q39336050) (← links)
- Mood Stabilizers and the Influence on Global Leukocyte DNA Methylation in Bipolar Disorder (Q39415079) (← links)
- Testosterone Depletion Induces Demethylation of Murine Reelin Promoter CpG Dinucleotides: A Preliminary Study (Q40364308) (← links)
- Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. (Q42216522) (← links)
- Nuclear and Mitochondrial DNA Methylation Patterns Induced by Valproic Acid in Human Hepatocytes (Q42379819) (← links)
- Does DNA methylation influence the effects of psychiatric drugs? (Q48062834) (← links)